Facebook
Twitter
LinkedIn
Forward
The AAP has comprehensively updated their recommendations regarding the disease of obesity in childhood. The incidence of obesity in childhood has not improved.
|
Obesity pharmacotherapy often is solely equated as therapeutic use of anti-obesity medications (AOMs). In this session, two important factors in obesity pharmacotherapy will be discussed.
|
CME/CE Expiration Date: 4/26/27*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
|
CME/CE Expiration Date: 4/26/27*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
|
CME/CE Expiration Date: 4/26/27*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
|
Is the intersection of Childhood Obesity and pediatric sleep problems merely confined to a discussion of poor sleep habits leading to weight gain?
|
This webinar will review current trends in the management of pediatric obesity.
|
This session will review the current state of pharmacology in the treatment of children and adolescents with obesity. Recorded during Overcoming Obesity 2022.
|
The initial contact with a child with obesity and their family is a critical part of patient care.
|
Recorded during Obesity Medicine 2022. CME/CE Expiration Date: 3/19/25
|